Levodopa/Carbidopa/Entacapone Teva

Levodopa/Carbidopa/Entacapone, the active ingredient in Levodopa/Carbidopa/Entacapone Teva, is an Antiparkinson agent presented as a tablet for oral use. It is used to manage Parkinson's disease symptoms in adult patients.

GNH USA supplies Levodopa/Carbidopa/Entacapone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa/Entacapone is indicated for Parkinson's disease and related motor fluctuation management.

- Parkinson's disease (early‑stage): improves motor symptoms such as bradykinesia, rigidity and tremor. - Parkinson's disease (advanced with motor fluctuations): reduces OFF time and increases ON time without troublesome dyskinesia. - Parkinson's disease (wearing‑off phenomenon): provides more stable central dopamine levels to smooth symptom control.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: may accompany nausea. - Dizziness: often related to orthostatic changes. - Orthostatic hypotension: drop in blood pressure upon standing. - Insomnia: difficulty falling or staying asleep. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: marked blood pressure decline requiring medical attention. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Cardiac arrhythmias: irregular heart rhythms. - Anaphylaxis: acute allergic reaction with airway compromise.

Before initiating therapy, clinicians should consider several safety aspects.

- Assess renal function: adjust therapy in severe impairment. - Monitor hepatic enzymes: entacapone may affect liver function. - Evaluate cardiovascular status: risk of orthostatic hypotension. - Review concomitant MAO‑B inhibitors: avoid combined use to prevent hypertensive events. - Educate patients on timing of doses with protein‑rich meals: protein can interfere with levodopa absorption. - Store at ambient temperature: keep in the original pack, protect from moisture.

Levodopa/Carbidopa/Entacapone can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: may precipitate hypertensive crisis. - Anticholinergic agents: can worsen confusion and cognitive impairment. - Antihypertensive drugs: additive blood‑pressure lowering effect.

Moderate Interactions (Monitor Closely): - Other dopaminergic agents (e.g., dopamine agonists): may increase risk of dyskinesia. - SSRIs or SNRIs: monitor for serotonin syndrome. - Iron or calcium supplements: may reduce levodopa absorption if taken simultaneously.